Latest 10-Q quarterly reports
NASDAQ
VSEC
Vse CORPVSE Corporation reported a substantial 65% year-over-year revenue increase for Q2 2026, fueled by strategic acquisitions and strong market demand in the aviation aftermarket.
OTC.Pink
Bright Mountain Media, Inc. reported a net loss of $3.2 million for Q2 2026, with revenue down 12% year-over-year, while advertising technology revenue saw a 26% increase.
NYSE
Prosperity Bancshares, Inc. announced significant increases in net interest income, total assets, and deposits for the second quarter ended June 30, 2026, driven by successful acquisitions and favorable market conditions.
NYSE
MUSA
Murphy USA INCMurphy USA Inc. announced a substantial increase in net income and revenues for the second quarter of 2026, driven by robust fuel and merchandise sales.
NASDAQ
Profound Medical Corp. reported a 62% increase in revenue for the first six months of 2026, driven by strong capital equipment sales, while operating expenses decreased.
NYSE
MET
Metlife INCMetLife Inc. announced robust financial results for the second quarter of 2026, showcasing significant year-over-year growth in adjusted earnings and premiums across key business segments.
NASDAQ
Opus Genetics reports substantial cash reserves and progress in gene therapy trials, alongside significant financing activities and continued operational losses.
NASDAQ
Alarm.com Holdings, Inc. announced its financial results for the second quarter of 2026, reporting an 11% increase in SaaS and license revenue and a 9% rise in total revenue, while net income saw a decrease compared to the prior year.
NASDAQ
Tractor Supply reported a 2.3% increase in Q2 net sales to $4.54 billion, but net income fell 16.1% to $360.7 million, impacted by impairment charges and higher operating expenses.
AMEX
Network-1 Technologies, Inc. reported a wider net loss for the second quarter of 2026, driven by increased operating expenses and no revenue, though a gain from an equity investment provided a partial offset.
NASDAQ
J&J Snack Foods Corp. reported a 6.2% decrease in net sales for the third quarter of fiscal 2026, alongside a 20.1% drop in net earnings, impacted by lower volumes in its Food Service segment.
NASDAQ
HSTM
Healthstream INCHealthStream Inc. announced robust Q2 2026 results, with revenues up 12.5% and net income increasing by 23.8%, driven by subscription services and strategic acquisitions.
NASDAQ
Aclaris Therapeutics reports increased R&D expenses and net losses in Q2 2026, driven by clinical trial advancements, while securing $57.9 million in financing.
NASDAQ
Clean Energy Fuels Corp. saw revenue increase in Q2 2026 driven by station construction sales and environmental credits, but reported a net loss and reduced cash from operations.
NASDAQ
Xenon Pharmaceuticals Inc. reported substantial net losses and highlighted the critical need for future funding to advance its neuroscience-focused drug development programs, particularly for azetukalner.
NASDAQ
Xenetic Biosciences reports increased royalty revenue in Q2 2026 but continues to face operational losses, while undergoing a strategic review process that may lead to significant corporate changes.
NASDAQ
CRVL
Corvel CORPCorVel Corporation announced a significant increase in revenue and net income for the first fiscal quarter ended June 30, 2026, driven by growth in its core service lines.
NASDAQ
BEST SPAC I Acquisition Corp. reports significant share redemptions and extends its business combination deadline to June 16, 2027, while facing substantial doubt about its going concern.
NASDAQ
FIVN
Five9, INCFive9, Inc. announced its second quarter 2026 financial results, showcasing a 10% increase in revenue and a significant rise in net income compared to the prior year period.
NASDAQ
Structure Therapeutics Inc. filed its Form 10-Q for the period ended June 30, 2026, detailing increased R&D expenses and a substantial net loss, while highlighting progress in its clinical pipeline.
NASDAQ
Senseonics Holdings, Inc. Q2 2026 filing shows a substantial increase in total revenue and gross profit, driven by US sales growth and the 365-day product, alongside significant investments in R&D and SG&A.
NASDAQ
Bridger Aerospace Group Holdings, Inc. reported a net loss of $0.5 million for the second quarter of 2026, with revenues slightly decreasing by 1% year-over-year, impacted by a significant drop in MRO and Other Services revenue.
NASDAQ
TALK
Talkspace, INCTalkspace reported a 13.6% revenue increase in Q2 2026 driven by Payor segment growth, but also saw a significant rise in G&A expenses due to merger-related costs.
NASDAQ
PDF Solutions, Inc. announced robust financial results for the second quarter of 2026, showcasing significant revenue increases and a return to net income, bolstered by a successful secondary offering.
NASDAQ
OABI
Omniab, INCOmniAb, Inc. announced its second quarter 2026 financial results, showcasing a substantial increase in total revenue driven by license and milestone payments, while continuing to report net losses and a decrease in cash reserves.
NYSE
Howmet Aerospace Inc. reported a substantial increase in second-quarter 2026 revenue and net income, driven by strong performance in aerospace markets and strategic acquisitions.
NYSE
RXO
Rxo, INCRXO, Inc. reported a 25% revenue increase for Q2 2026, reaching $1.8 billion, but continued to post net losses and saw its cost of transportation services rise as a percentage of revenue.
NASDAQ
Red Cat Holdings, Inc. (RCAT) announced a substantial increase in revenues for the quarter ended June 30, 2026, driven by expanded drone deliveries and strategic acquisitions, alongside increased operating expenses.
NASDAQ
Aeva Technologies (AEVA) filed its Q2 2026 10-Q, revealing a significant increase in professional services revenue but continued operating losses and a substantial cash burn, raising concerns about future liquidity.
NASDAQ
Lyell Immunopharma's Q2 2026 report shows continued net losses and operating expenses, though progress is noted in its CAR T-cell therapy development for LBCL and mCRC.